{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:05:24Z","timestamp":1775775924119,"version":"3.50.1"},"reference-count":37,"publisher":"Institute of Physiology of the Czech Academy of Sciences","issue":"3\/2024","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>We assessed the prognostic utility of the new perinephric fat adherence risk score \u2013 Mayo Adhesive Probability (MAP), in patients of East Asian ethnicity undergoing either laparoscopic partial nephrectomy (LPN) or laparoscopic radical nephrectomy (LRN). A retrospective analysis of clinical data was carried out on 169 patients who either underwent LPN or LRN surgery. These patients were categorized into two groups, group A (0-2 points) and group B (3-4 points) using the new MAP score. The overall clinical data between these two groups was compared and potential risk factors were investigated using logistic regression analyses. The new MAP score yielded an area under the curve of 0.761 (95 % CI: 0.691-0.831), indicating its effectiveness. Group B had a significantly higher incidence of adherent perirenal fat (APF) during surgery (p&lt;0.001) and had a greater average age (p&lt;0.001). There was an increased prevalence of hypertension (p=0.009), type 2 diabetes mellitus (p&lt;0.001), and MAFLD (p&lt;0.001) in group B. Additionally, there were significant differences in posterior perinephric fat thickness (p&lt;0.05), lateral perinephric fat thickness (p&lt;0.001), and perinephric stranding (p&lt;0.001) between the two groups. The new MAP score holds significance in predicting APF in people of East Asian ethnicity undergoing LPN or LRN, and there is a strong correlation between elevated MAP scores and risk factors such as MAFLD and advanced age.<\/jats:p>","DOI":"10.33549\/physiolres.935297","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T13:59:08Z","timestamp":1721224748000},"page":"393-403","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the Prognostic Utility of the New Mayo Adhesive Probability Score in East Asian Populations and its Correlation with Metabolic-Associated Fatty Liver Disease"],"prefix":"10.33549","author":[{"given":"Y","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z-C","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-L","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X-M","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q-Q","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-L","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.\tGBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023;402:203-234. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6","DOI":"10.2139\/ssrn.4877144"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.\tEslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, ET AL. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020;73:202-209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tNan Y, An J, Bao J, Chen H, Chen Y, Ding H, Dou X, ET AL. The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. J Hepatol 2021;75:454-461. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.003","DOI":"10.1016\/j.jhep.2021.05.003"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.\tDavidiuk AJ, Parker AS, Thomas CS, Leibovich BC, Castle EP, Heckman MG, Custer K, Thiel DD. Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy. Eur Urol 2014;66:1165-1171. https:\/\/doi.org\/10.1016\/j.eururo.2014.08.054","DOI":"10.1016\/j.eururo.2014.08.054"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.\tBorregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE, Wang X, ET AL. Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy. Eur Urol Focus 2021;7:397-403. https:\/\/doi.org\/10.1016\/j.euf.2019.10.007","DOI":"10.1016\/j.euf.2019.10.007"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.\tKadowaki T, Sekikawa A, Murata K, Maegawa H, Takamiya T, Okamura T, El-Saed A, ET AL. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 2006;30:1163-1165. https:\/\/doi.org\/10.1038\/sj.ijo.0803248","DOI":"10.1038\/sj.ijo.0803248"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.\tYanishi M, Kinoshita H, Koito Y, Taniguchi H, Mishima T, Sugi M, Matsuda T. Adherent Perinephric Fat Is a Surgical Risk Factor in Laparoscopic Single-Site Donor Nephrectomy: Analysis Using Mayo Adhesive Probability Score. Transplant Proc 2020;52:84-88. https:\/\/doi.org\/10.1016\/j.transproceed.2019.11.027","DOI":"10.1016\/j.transproceed.2019.11.027"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.\tDariane C, Le Guilchet T, Hurel S, Audenet F, Beaugerie A, Badoual C, Tordjman J, ET AL. Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies. Urol Oncol 2017;35:39.e9-39.e17. https:\/\/doi.org\/10.1016\/j.urolonc.2016.09.008","DOI":"10.1016\/j.urolonc.2016.09.008"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.\tKawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, ET AL. Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy. Urol Int 2018;101:437-442. https:\/\/doi.org\/10.1159\/000494068","DOI":"10.1159\/000494068"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.\tDavidiuk AJ, Parker AS, Thomas CS, Heckman MG, Custer K, Thiel DD. Prospective evaluation of the association of adherent perinephric fat with perioperative outcomes of robotic-assisted partial nephrectomy. Urology 2015;85:836-842. https:\/\/doi.org\/10.1016\/j.urology.2014.12.017","DOI":"10.1016\/j.urology.2014.12.017"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.\tLee SM, Robertson I, Stonier T, Simson N, Amer T, Aboumarzouk OM. Contemporary outcomes and prediction of adherent perinephric fat at partial nephrectomy: a systematic review. Scand J Urol 2017;51:429-434. https:\/\/doi.org\/10.1080\/21681805.2017.1357656","DOI":"10.1080\/21681805.2017.1357656"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.\tWHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies [published correction appears in Lancet 2004;363:902]. Lancet 2004;363:157-163. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3","DOI":"10.1016\/s0140-6736(03)15268-3"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.\tYuan Q, Wang H, Gao P, Chen W, Lv M, Bai S, Wu J. Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China. Int J Environ Res Public Health 2022;19:2096. https:\/\/doi.org\/10.3390\/ijerph19042096","DOI":"10.3390\/ijerph19042096"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.\tEskandari M, Alizadeh Bahmani AH, Mardani-Fard HA, Karimzadeh I, Omidifar N, Peymani P. Evaluation of factors that influenced the length of hospital stay using data mining techniques. BMC Med Inform Decis Mak 2022;22:280. https:\/\/doi.org\/10.1186\/s12911-022-02027-w","DOI":"10.1186\/s12911-022-02027-w"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.\tKhosravizadeh O, Vatankhah S, Bastani P, Kalhor R, Alirezaei S, Doosty F. Factors affecting length of stay in teaching hospitals of a middle-income country. Electron Physician 2016;8:3042-3047. https:\/\/doi.org\/10.19082\/3042","DOI":"10.19082\/3042"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.\tHotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature 2017;542:177-185. https:\/\/doi.org\/10.1038\/nature21363","DOI":"10.1038\/nature21363"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.\tYounossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. https:\/\/doi.org\/10.1002\/hep.28431","DOI":"10.1002\/hep.28431"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.\tLiu J, Ayada I, Zhang X, Wang L, Li Y, Wen T, Ma Z, ET AL. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults. Clin Gastroenterol Hepatol 2022;20:e573-e582. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.030","DOI":"10.1016\/j.cgh.2021.02.030"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.\tLiang Y, Chen H, Liu Y, Hou X, Wei L, Bao Y, Yang C, ET AL. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China. J Clin Endocrinol Metab 2022;107:88-97. https:\/\/doi.org\/10.1210\/clinem\/dgab641","DOI":"10.1210\/clinem\/dgab641"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20.\tNan Y, An J, Bao J, Chen H, Chen Y, Ding H, Dou X, ET AL. The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. J Hepatol 2021;75:454-461. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.003","DOI":"10.1016\/j.jhep.2021.05.003"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.\tEslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, ET AL. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020;73:202-209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.\tNguyen VH, Le MH, Cheung RC, Nguyen MH. Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and\/or MAFLD. Clin Gastroenterol Hepatol 2021;19:2172-2181.e6. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.029","DOI":"10.1016\/j.cgh.2021.05.029"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.\tNoubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, Tounouga DN, ET AL. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract 2022;188:109924. https:\/\/doi.org\/10.1016\/j.diabres.2022.109924","DOI":"10.1016\/j.diabres.2022.109924"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24.\tChi ZC. Research status and progress of metabolic associated fatty liver disease. (Article in Chinese) Shijie Huaren Xiaohua Zazhi 2022;30:1-16. https:\/\/doi.org\/10.11569\/wcjd.v30.i1.1","DOI":"10.11569\/wcjd.v30.i1.1"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.\tGBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023;402:203-234. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6","DOI":"10.2139\/ssrn.4877144"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.\tHotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867. https:\/\/doi.org\/10.1038\/nature05485","DOI":"10.1038\/nature05485"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.\tSakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci 2021;22:4156. https:\/\/doi.org\/10.3390\/ijms22084156","DOI":"10.3390\/ijms22084156"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.\tSpranger J, Kroke A, M\u00f6hlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52:812-817. https:\/\/doi.org\/10.2337\/diabetes.52.3.812","DOI":"10.2337\/diabetes.52.3.812"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.\tPickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823. https:\/\/doi.org\/10.2337\/diacare.27.3.813","DOI":"10.2337\/diacare.27.3.813"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.\tHan R, Ma J, Li H. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Front Med 2018;12:645-657. https:\/\/doi.org\/10.1007\/s11684-018-0645-9","DOI":"10.1007\/s11684-018-0645-9"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.\tFisman EZ, Tenenbaum A. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol 2014;13:103. https:\/\/doi.org\/10.1186\/1475-2840-13-103","DOI":"10.1186\/1475-2840-13-103"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.\tZhang H, Niu Y, Gu H, Lu S, Zhang W, Li X, Yang Z, Qin L, Su Q. Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease. J Clin Lab Anal 2019;33:e22709. https:\/\/doi.org\/10.1002\/jcla.22709","DOI":"10.1002\/jcla.22709"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.\tYang Y, Li S, Xu Y, Ke J, Zhao D. The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes 2022;15:1505-1515. https:\/\/doi.org\/10.2147\/DMSO.S350579","DOI":"10.2147\/dmso.s350579"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.\tFranceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014;69(Suppl 1):S4-S9. https:\/\/doi.org\/10.1093\/gerona\/glu057","DOI":"10.1093\/gerona\/glu057"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.\tKuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev 2009;8:339-348. https:\/\/doi.org\/10.1016\/j.arr.2009.06.001","DOI":"10.1016\/j.arr.2009.06.001"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.\tTrayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355. https:\/\/doi.org\/10.1079\/BJN20041213","DOI":"10.1079\/bjn20041213"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.\tDemaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, ET AL. Cancer and inflammation: promise for biologic therapy. J Immunother 2010;33:335-351. https:\/\/doi.org\/10.1097\/CJI.0b013e3181d32e74","DOI":"10.1097\/cji.0b013e3181d32e74"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T13:59:15Z","timestamp":1721224755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2024\/73_393.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":37,"journal-issue":{"issue":"3\/2024","published-online":{"date-parts":[[2024,7,10]]}},"URL":"https:\/\/doi.org\/10.33549\/physiolres.935297","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,10]]}}}